313 results on '"Jacinto, Jorge"'
Search Results
2. Management of Poststroke Spasticity With Botulinum Toxin Type A Based on Patient-Centered Treatment Goals
3. Predictors of real-world response in adults treated with botulinumtoxin-A for upper limb spasticity
4. Effectiveness of AbobotulinumtoxinA in Adults with Lower Limb Spasticity: Top Line Results from the AboLiSh Observational Study (P7-11.020)
5. Leg Activity Measure (LegA) Sensitivity to Change Following Treatment of Lower Limb Spasticity with a Single Cycle of AbobotulinumtoxinA in an Ambulatory Population
6. Effectiveness of AbobotulinumtoxinA in Adults With Lower Limb Spasticity: Top Line Results From the AboLiSh Observational Study
7. Social Media Listening Study to Understand the Journey and Unmet Needs of Patients Living With PSS
8. Outcome Measurement and Goal-Setting Recommendations in the Multipattern Treatment of Shoulder Spasticity With Botulinum Neurotoxin
9. Choice of Shoulder Muscles for the Multi-Pattern Treatment of Upper Limb Spasticity With Botulinum Neurotoxin Injections
10. Outcome measurement and goal-setting recommendations in the multipattern treatment of shoulder spasticity with botulinum neurotoxin
11. Choice of shoulder muscles for the multi-pattern treatment of upper limb spasticity with botulinum neurotoxin injections
12. Selecting Goals and Target Muscles for Botulinum Toxin A Injection Using the Goal Oriented Facilitated Approach to Spasticity Treatment (GO-FAST) Tool
13. Clinical presentation of patients with lower limb spasticity undergoing routine treatment with botulinum toxin: baseline findings from an international observational study
14. Improvement in quality of life of transfemoral amputees: Comparison between 2 types of transfemoral sockets and their influence on functionality and user comfort - A case report
15. Leg Activity Measure (LegA) sensitivity to change following treatment of lower limb spasticity with a single cycle of abobotulinumtoxinA in an ambulant population (P12-8.010)
16. A practical guide to botulinum neurotoxin treatment of shoulder spasticity 2: Injection techniques, outcome measurement scales, and case studies
17. A practical guide to botulinum neurotoxin treatment of shoulder spasticity 1: Anatomy, physiology, and goal setting
18. Worldwide Survey of Clinician Practice on use of Adjunctive Therapies Following Botulinum Toxin Injection for Spasticity
19. Experiences of patients with poststroke spasticity throughout a botulinum toxin treatment cycle: Results from a prospective ethnographic study
20. Factors Associated With Favorable Response in Real-World Use of Botulinum Toxin Type A Products for Adult Patients With Upper Limb Spasticity
21. Assessing the Effectiveness of AbobotulinumtoxinA Injections for Adult Lower Limb Spasticity in Routine Clinical Practice: Methodology and Baseline Data for the AboLiSh Study
22. How Prevalent and Relevant Are Adjuvant Therapies in Post-Stroke Spasticity Clinical Practice in the 20 Years’ Experience of a Reference Spasticity Clinic?
23. How Do Goal Categories Influence the Most Frequently Targeted Muscles for Post-Stroke Spasticity? Twenty Years of Experience of a Reference Center
24. How Different or Similar Is Management of Post-Stroke Spasticity With Botulinum Toxin When Pain Is Present?
25. What Categories of Goals Are More Impacted by Adjuvant Therapies in Post-Stroke Spasticity Management With Botulinum Toxin Type A? An Analysis of 20 Years of Real-World Data
26. Long-Term Use of Botulinum Toxin: Is Primary Goal Achievement Sustainable for Poststroke Spasticity?
27. Controlling Post-Stroke Spasticity With Botulinum Toxin in the Long Term: Which Limbs and How Many Muscles Are We Treating?
28. How Do Injection Guidance Methods Relate to Doses Used, Targeted Limbs, And Goal Achievement?
29. History of Injection Guidance Practice in a Reference Botulinum Toxin Type A Clinic Over 20 Years
30. Module 4
31. Baseline presentation and goal setting for patients undergoing treatment for lower limb spasticity with abobotulinumtoxinA in routine practice. Data from the AboLiSh study (S10.003)
32. Most Frequently Injected Muscles for Lower Limb Spasticity in Routine Practice: AboLiSh Study Baseline Data
33. Common goal areas in the treatment of upper limb spasticity: a multicentre analysis
34. The spasticity-related quality of life 6-dimensions instrument in upper-limb spasticity: Development and responsiveness
35. The spasticity-related quality of life 6-dimensions instrument in upper-limb spasticity: A first psychometric evaluation
36. Botulinum Toxin Services for Neurorehabiliation: Recommendations for Challenges and Opportunities during the COVID-19 Pandemic
37. Fenestração e aspiração ecoguiada de neoformações ósseas no controlo da dor do amputado
38. Botulinum Toxin Services for Neurorehabiliation: Recommendations for Challenges and Opportunities during the COVID-19 Pandemic.
39. Patient Perceptions of Spasticity and Treatment Satisfaction Over the Course of a Botulinum Neurotoxin A (BoNT-A) Treatment Cycle: An Ethnographic Study of Stroke Survivors (1381)
40. Real-life data on the time to retreatment with botulinum toxin A in upper limb spasticity management (1408)
41. OrthoRehab: Development of a New Methodology for the Comparison Study Between Different Types of Ankle–Foot Orthoses in Foot Dysfunction
42. Longitudinal goal attainment with integrated upper limb spasticity management including botulinum toxin A: Primary results from the ULIS-III study
43. Economic outcomes in real-world use of botulinum toxin-A products for adult patients with upper limb spasticity: A UK perspective
44. Patient experiences of symptom re-emergence: Findings from 2 online patient surveys in spasticity and cervical dystonia
45. Real-life data on the time to retreatment with botulinum toxin type A in upper limb spasticity management
46. Cervical dystonia management with abobotulinumtoxinA using patient-centered goal-setting and gas in a young adult patient with dyskinetic cerebral palsy
47. Real-life use of botulinum toxin type A in poststroke spasticity: Is there a time window to start treatment?
48. Real-life criteria for use of maximal and supramaximal doses of abobotulinumtoxinA in poststroke spasticity: Is it worth it?
49. Success of botulinum toxin treatment in poststroke spasticity in real-life clinical practice: Do the formulations and doses matter?
50. The spasticity-related quality of life 6-dimensions tool (SQoL-6D) in upper limb spasticity: A first psychometric evaluation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.